BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 22139803)

  • 21. Carcinoma of the prostate in young patients: a report of two cases.
    Jadeja NA; Dogra PN; Gupta NP
    Urol Int; 1994; 52(1):48-51. PubMed ID: 8140682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broadsheet number 45: thin core biopsy of prostate. The Royal College of Pathologists of Australia.
    Delahunt B; Nacey JN
    Pathology; 1998 Aug; 30(3):247-56. PubMed ID: 9770188
    [No Abstract]   [Full Text] [Related]  

  • 23. [Contemporary concept of the diagnosis of prostate cancer].
    Vinnik YY; Andreichikov AV; Klimov NY
    Urologiia; 2017 Jun; (2):110-115. PubMed ID: 28631917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare Costs of Post-Prostate Biopsy Sepsis.
    Gross MD; Alshak MN; Shoag JE; Laviana AA; Gorin MA; Sedrakyan A; Hu JC
    Urology; 2019 Nov; 133():11-15. PubMed ID: 31229516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The state of prostate cancer screening in the United States.
    Haas GP; Montie JE; Pontes JE
    Eur Urol; 1993; 23(3):337-47. PubMed ID: 8508885
    [No Abstract]   [Full Text] [Related]  

  • 26. Financial toxicity associated with treatment of localized prostate cancer.
    Imber BS; Varghese M; Ehdaie B; Gorovets D
    Nat Rev Urol; 2020 Jan; 17(1):28-40. PubMed ID: 31792431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structured reporting of prostate cancer-self-development of a digital solution for prostate biopsies].
    Reis H; Skottky S; Hager T; Hadaschik B; Waue V; Zwönitzer R
    Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):94-100. PubMed ID: 36301350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of costs of transrectal prostate biopsy.
    Fandella A
    Urologia; 2011; 78(4):288-92. PubMed ID: 22139803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies.
    Ekwueme DU; Stroud LA; Chen Y
    Prev Chronic Dis; 2007 Oct; 4(4):A100. PubMed ID: 17875244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: Early detection strategies.
    Coley CM; Barry MJ; Fleming C; Wasson JH; Fahs MC; Oesterling JE
    Urology; 1995 Aug; 46(2):125-41. PubMed ID: 7542817
    [No Abstract]   [Full Text] [Related]  

  • 31. The clinical and economic implications of specimen provenance complications in diagnostic prostate biopsies.
    Wojno K; Hornberger J; Schellhammer P; Dai M; Morgan T
    J Urol; 2015 Apr; 193(4):1170-7. PubMed ID: 25463992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of transrectal prostatic ultrasonography in the evaluation of patients with prostatic carcinoma.
    Waterhouse RL; Resnick MI
    J Urol; 1989 Feb; 141(2):233-9. PubMed ID: 2643718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada.
    Smith-Palmer J; Takizawa C; Valentine W
    BMC Urol; 2019 Mar; 19(1):19. PubMed ID: 30885200
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.